Navigation Links
See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC
Date:3/31/2008

h extends imaging capabilities through virtually unrestricted C-arm positioning. The ability to deliver two non- concentric rotations supports advanced cross-sectional imaging, which is not achievable with traditional C-arm systems. The Artis zeego makes it possible for the position of the isocenter to be adjusted according to the procedural needs or the height of the physician, which is particularly beneficial to a physician during lengthy procedures, while wearing a heavy lead-shielded apron. Furthermore, the Artis zeego can be parked compactly to give the clinical team easier access to the patient, making it ideal for hybrid rooms.

Additionally, Frost & Sullivan recently selected the Artis zeego as winner of the 2008 Frost & Sullivan Technology Innovation Award at their Excellence in Medical Technologies Awards banquet.

Faster, More Effective Procedures

The entire Artis zee family of systems features an enhanced imaging chain -- spanning acquisition to processing and documentation -- that delivers sharply detailed images required for interventional procedures, enhances clarity in 2D imaging, and enables an array of 3D imaging applications to help enhance clinical decision-making.

"The interventional cardiologist now faces greater demands than ever as the number of minimally invasive procedures grows and the need to visualize fine vessels and small devices is increasingly critical," said Claus Grill, Vice President, Angiography, Cardiac, and X-ray Systems, Siemens Medical Solutions USA, Inc. "Siemens developed the Artis zee portfolio of products to provide clinicians with excellent image quality, enabling them to diagnose and treat with greater speed, efficiency and precision, all the while improving patient outcomes and workflow."

From 2D to 4D: Imaging a moving structure, such as the heart, has always been a challenge. Now, with the Artis zee, outstanding image quality is provided from 2D fluoroscopy and 3D imaging and even a 4
'/>"/>

SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Newer antidepressants led to less, not more, teen suicides
2. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
3. Hand-held computers prod older adults to exercise more, Stanford study shows
4. PTSD associated with more, longer hospitalizations
5. Asbestos No More: Historic Asbestos Ban Passage Imminent
6. Siemens Extends Tender Offer for Acquisition of Dade Behring
7. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
8. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
9. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
10. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
11. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5Video 3A Plan for Long Term Care Before the Crisis Hits 47797 1Video 3A Plan for Long Term Care Before the Crisis Hits 47797 2Video 3A Plan for Long Term Care Before the Crisis Hits 47797 3Video 3A Plan for Long Term Care Before the Crisis Hits 47797 4Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 1Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 3Stepping up minority recruiting 47791 1Stepping up minority recruiting 47791 2Stepping up minority recruiting 47791 3